APA (7th ed.) Citation

Zivin, J. A., Sehra, R., Shoshoo, A., Albers, G. W., Bornstein, N. M., Dahlof, B., . . . Hacke, W. (2014). NeuroThera® Efficacy and Safety Trial - 3 (NEST-3): A double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® laser system for the treatment of acute ischemic stroke within 24 h of stroke onset. International journal of stroke, 9, .

Chicago Style (17th ed.) Citation

Zivin, Justin A., et al. "NeuroThera® Efficacy and Safety Trial - 3 (NEST-3): A Double-blind, Randomized, Sham-controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy with the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke Within 24 H of Stroke Onset." International Journal of Stroke 9 (2014).

MLA (9th ed.) Citation

Zivin, Justin A., et al. "NeuroThera® Efficacy and Safety Trial - 3 (NEST-3): A Double-blind, Randomized, Sham-controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy with the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke Within 24 H of Stroke Onset." International Journal of Stroke, vol. 9, 2014.